Ephedrine Decreases Vesicular Monoamine Transporter-2 Function

Synapse - United States
doi 10.1002/syn.20896
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

The Vesicular Monoamine Transporter 2: An Underexplored Pharmacological Target

Neurochemistry International
Molecular NeuroscienceCell BiologyCellular
2014English

Genetic Variation in the Vesicular Monoamine Transporter

Journal of Head Trauma Rehabilitation
Physical TherapySports TherapyNeurologyRehabilitation
2017English

Lobelane Analogues as Novel Ligands for the Vesicular Monoamine Transporter-2

Bioorganic and Medicinal Chemistry
Organic ChemistryMolecular MedicineMolecular BiologyBiochemistryClinical BiochemistryPharmaceutical ScienceDrug Discovery
2005English

Therapeutic Doses of Amphetamine and Methylphenidate Selectively Redistribute the Vesicular Monoamine Transporter-2

European Journal of Pharmacology
Pharmacology
2007English

A Novel Potential Positron Emission Tomography Imaging Agent for Vesicular Monoamine Transporter Type 2

PLoS ONE
Multidisciplinary
2016English

In Vivo Assessment of Vesicular Monoamine Transporter Type 2 in Dementia With Lewy Bodies and Alzheimer Disease

Archives of Neurology
2011English

Vesicular Monoamine Transporter 2 Regulates the Sensitivity of Rat Dopaminergic Neurons to Disturbed Cytosolic Dopamine Levels

Brain Research
NeuroscienceNeurologyDevelopmental BiologyMolecular Biology
2007English

Vesicular Monoamine Transporters: Structure-Function, Pharmacology, and Medicinal Chemistry

Medicinal Research Reviews
Drug DiscoveryMolecular MedicinePharmacology
2010English

Long Term Stimulation Changes the Vesicular Monoamine Transporter Content of Chromaffin Granules

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1995English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy